Alexion Pharmaceuticals VP of Finance Salary | Comparably
Alexion Pharmaceuticals Claimed Company
Medicine/ Drug Developer and distributor read more
EMPLOYEE
PARTICIPANTS
46
TOTAL
RATINGS
347
HR or Marketing? Claim Your Free Employer Account

Alexion Pharmaceuticals VP of Finance Salary

The average Alexion Pharmaceuticals VP of Finance earns an estimated $222,915 annually. Alexion Pharmaceuticals' VP of Finance compensation is $16,385 more than the US average for a VP of Finance.

The Finance Department at Alexion Pharmaceuticals earns $6,312 more on average than the Operations Department.

Last updated 2 years ago.

$50k
$90k
$145k
$200k
$309k
$430k
$518k
$222,915
Average Compensation
$222,915
avg. base

VP of Finance Salaries at Alexion Pharmaceuticals

VPs of Finance earn $113,520 more than Accounting Managers.

Accounting Manager
$109k*
Accountant
$89k*
Financial Analyst
$89k*
Business Analyst
$88k*
Senior Accountant
$86k*
* estimated salary

Compensation at Alexion Pharmaceuticals by Department

The Finance Department averages $6,312 more than the Operations Department, and $5,435 less than the Marketing Department

Marketing
$89,214 Avg. total comp.
+$5k
Finance
$83,779 Avg. total comp.
Operations
$77,467 Avg. total comp.
-$6k

VP of Finance Compensation by Gender (All Companies)

The average female VP of Finance at companies similar size to Alexion Pharmaceuticals reported making $231,000, while the average male VP of Finance at similar sized companies reported making $214,467.

VP of Finance Compensation by Ethnicity (All Companies)

The average Caucasian VP of Finance at companies similar size to Alexion Pharmaceuticals reported making $223,611, while the average Asian or Pacific Islander VP of Finance at similar sized companies reported making $176,500.

How VPs of Finance at Alexion Pharmaceuticals Rate Their Compensation

The majority of VPs of Finance at Alexion Pharmaceuticals believe they're compensated fairly. 100% of VPs of Finance at Alexion Pharmaceuticals say they receive annual bonuses, and the vast majority (71%) are satisfied with their benefits. See more compensation ratings at Alexion Pharmaceuticals

×
Rate your company